Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection

Manuel G Feria1, Cecilia Chang2, Eduardo Ticona3,4

  • 1Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Insights

Latent tuberculosis infection (LTBI) is linked to higher cardiovascular risk. LTBI patients show altered monocytes with increased inflammation, potentially contributing to coronary artery disease (CAD).

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Infectious Diseases

Background:

  • Latent tuberculosis infection (LTBI) is increasingly recognized as a risk factor for cardiovascular disease.
  • Monocyte activation and inflammatory profiles may link LTBI to coronary artery disease (CAD).

Purpose of the Study:

  • To investigate monocyte activation and pro-inflammatory profiles in individuals with LTBI.
  • To determine the association between these monocyte alterations and CAD in the LTBI population.

Main Methods:

  • QuantiFERON-TB testing identified LTBI in adults (40-70 years) in Lima, Peru.
  • Coronary computed tomography angiography assessed CAD, and flow cytometry profiled monocyte subsets.
  • Monocytes were stimulated with lipopolysaccharide to measure interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) responses.

Main Results:

  • Individuals with LTBI showed higher expression of CX3CR1 and CD36 on monocyte subsets.
  • LTBI patients had a greater proportion of nonclassical monocytes expressing IL-6 and TNF-α.
  • Lower CX3CR1 and CD36 expression on monocytes correlated with CAD in LTBI individuals.

Conclusions:

  • LTBI is associated with distinct monocyte alterations, suggesting heightened inflammation and altered tissue migration.
  • These monocyte changes may play a role in the pathogenesis of cardiovascular disease in LTBI patients.
Abstract

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
296
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
409
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225